WHO

GLOBAL POLIOVIRUS RISK MANAGEMENT AND MODELING

Launched in 1988, the Global Polio Eradication Initiative (GPEI) stands out as one of the largest, internationally coordinated global public health major projects conducted to date, with cumulative spending of over $16.5 billion for 1988–2018, according to the World Health Organization (WHO). More than 30 years later, stubborn outbreaks of wild poliovirus still occur in Afghanistan and Pakistan, where cases have been increasing since 2018. The global eradication of polio continues to be an elusive goal.

Remdesivir for COVID-19: FDA Approved but Still Unproven

In a review of evidence from the most reliable data from randomized trials to find likely small-to-moderate effects of remdesivir, researchers say that totality of evidence compiled before the WHO trial results justifies compassionate use of remdesivir for severely ill patients. A smaller trial in China showed significantly decreased mean recovery time but no suggestion of a mortality benefit. ACTT-1 found the same mean recovery time and a suggestion of a mortality benefit that did not achieve statistical significance.

WashU Expert: America gains nothing by leaving WHO

President Donald Trump’s recent announcement to suspend U.S. funding to, and withdraw from, the World Health Organization is “counter to our interests in addressing our needs to save the lives and further the health of Americans, as well as an abandonment of America’s position as a global leader,” says the director of Washington University in St.

WashU Expert: WHO withdrawal may not be legal

President Donald Trump announced July 7 that the United States has officially begun to withdraw from the World Health Organization (WHO). Trump may or may not have the authority to do so, says an expert on health law at Washington University in St. Louis.“It’s not clear that the president can unilaterally withdraw the United States from membership in the WHO,” said Rachel Sachs, associate professor of law and a renowned expert on health policy and drug law.

ARN Board Member Maureen Musto Selected for Development Group Working on the World Health Organization “Rehabilitation 2030” Initiative

The Association of Rehabilitation Nurses is proud to announce that ARN Board Member Maureen Musto, MS RN APRN-CNS ACNS-BC CRRN, has been selected to serve on the Development Group for Traumatic Brain Injury and Parkinson’s Disease working on development of the World Health Organization (WHO) Rehabilitation Programme’s Package of Interventions for Rehabilitation (PRI).

New Tool Monitors Real Time Mutations In Flu

A Rutgers-led team has developed a tool to monitor influenza A virus mutations in real time, which could help virologists learn how to stop viruses from replicating. The gold nanoparticle-based probe measures viral RNA in live influenza A cells, according to a study in The Journal of Physical Chemistry C. It is the first time in virology that experts have used imaging tools with gold nanoparticles to monitor mutations in influenza, with unparalleled sensitivity.

Epilepsy is a threat to public health, says international report

Worldwide, more than 50 million people are living with epilepsy. As many as 37 million are not receiving treatment, though it can cost as little as US$5 a year and eliminates seizures about two-thirds of the time. These findings and many others are published in “Epilepsy: A public health imperative”, a report produced by ILAE, the World Health Organization and the International Bureau for Epilepsy.

Epilepsy is a threat to public health, says international report

Worldwide, more than 50 million people are living with epilepsy. As many as 37 million are not receiving treatment, though it can cost as little as US$5 a year and eliminates seizures about two-thirds of the time. These findings and many others are published in “Epilepsy: A public health imperative”, a report produced by ILAE, the World Health Organization and the International Bureau for Epilepsy.